Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sands

Showing results (181-190 of 513) with videos related to

Pageof 52
Sort By:
Gastroenterology|July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacyF Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Clinical and Experimental Gastroenterology|July 2, 2020
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1Edward V Loftus, Bruce E Sands, Jean-Frédéric Colombel, et al.
Circulation|January 1, 1989
Power spectrum analysis of heart rate variability in human cardiac transplant recipientsK E Sands, M L Appel, L S Lilly, et al.
Journal of Vascular Surgery|September 1, 1992
Contemporary surgical management of renovascular diseaseK J Hansen, S M Starr, R E Sands, et al.
The American Journal of Gastroenterology|April 4, 2018
ACG Clinical Guideline: Management of Crohn's Disease in AdultsGary R Lichtenstein, Edward V Loftus, Kim L Isaacs, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasmsC G Willett, C J Ooi, A L Zietman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 28, 2007
A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosisMilton D Rossman, Lee S Newman, Robert P Baughman, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa StudyWilliam J Sandborn, Paul Rutgeerts, Jean-Frédéric Colombel, et al.
The American Journal of Gastroenterology|July 4, 2014
Comment on 'anti-adhesion therapies and the rule of 3 for rare events'Brian G Feagan, Jean-Frederic Colombel, Stephen B Hanauer, et al.
BMC Gastroenterology|December 21, 2023
Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn's diseaseSilvio Danese, Andrew Beaton, Elizabeth A Duncan, et al.
Pageof 52

Showing results (181-190 of 513) with videos related to

Sort By:
Pageof 52
Gastroenterology|July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacyF Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Clinical and Experimental Gastroenterology|July 2, 2020
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1Edward V Loftus, Bruce E Sands, Jean-Frédéric Colombel, et al.
Circulation|January 1, 1989
Power spectrum analysis of heart rate variability in human cardiac transplant recipientsK E Sands, M L Appel, L S Lilly, et al.
Journal of Vascular Surgery|September 1, 1992
Contemporary surgical management of renovascular diseaseK J Hansen, S M Starr, R E Sands, et al.
The American Journal of Gastroenterology|April 4, 2018
ACG Clinical Guideline: Management of Crohn's Disease in AdultsGary R Lichtenstein, Edward V Loftus, Kim L Isaacs, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasmsC G Willett, C J Ooi, A L Zietman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 28, 2007
A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosisMilton D Rossman, Lee S Newman, Robert P Baughman, et al.
Journal of Crohn'S & Colitis|March 24, 2017
Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa StudyWilliam J Sandborn, Paul Rutgeerts, Jean-Frédéric Colombel, et al.
The American Journal of Gastroenterology|July 4, 2014
Comment on 'anti-adhesion therapies and the rule of 3 for rare events'Brian G Feagan, Jean-Frederic Colombel, Stephen B Hanauer, et al.
BMC Gastroenterology|December 21, 2023
Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn's diseaseSilvio Danese, Andrew Beaton, Elizabeth A Duncan, et al.
Pageof 52